The Evidence Advantage: How Life Sciences Leaders Are Winning With Real-World Data

Moderator

Myla Maloney, MBA, Premier Applied Sciences, Charlotte, NC, United States

Speakers

Thomas Dougherty, Novo Nordisk, Dallas, PA, United States; Ryan Farej, BS, Bayer US LLC, Clinton, NJ, United States; Stephen Johnston, PhD, Johnson & Johnson, Annapolis, MD, United States; Cheng Yang, PhD, Takeda Pharmaceuticals, Lexington, MA, United States

Real-world data (RWD) is increasingly used for demonstrating value, supporting HEOR, and strengthening market access. In this panel, speakers will discuss approaches to translating RWD into evidence that can inform healthcare decision-making across stakeholders. Attendees will gain perspectives on how RWD may be used to support evidence generation, decision-making, and communication of value in healthcare systems.
Learning Objectives:

  • Explain the potential role of RWD in HEOR and market access.
  • Explore approaches for generating evidence from real-world data sources.
  • Recognize opportunities to inform healthcare decision-making and value assessment using RWD.
Sponsored by Corporate Partner, Premier Applied Sciences

Topic

Health Policy & Regulatory, Methodological & Statistical Research, Real World Data & Information Systems

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×